Zota Health Care Ltd (NSE: ZOTA) is a Surat, Gujarat-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹4,585 Cr, it ranks #877 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 9 in Non-Prescription Drugs. At ₹1,297.00 (as of 16 Nov 2026), the share price is 25.5% below its 52-week high of ₹1,740.00 and 26.9% above its 52-week low of ₹1,022.00. The share price is down 15.1% over one year and up 4.5% over three months.
| Current Price | ₹1,297.00 |
|---|---|
| Market Cap | ₹4,585 Cr |
| NSE Symbol | ZOTA |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -16.05% |
| Return on Assets | -5.07% |
| 52-Week Range | ₹1,022.00 – ₹1,740.00 |
| 1-Year Price Change | -15.1% |
| 3-Month Price Change | +4.5% |
| Beta (1Y) | 0.31 |
| Dividend Yield | 0.08% |
| Headquarters | Surat, Gujarat |
| Website | www.zotahealthcare.com |
| Revenue | ₹199 Cr |
|---|---|
| Net Profit | ₹-26 Cr |
| Net Margin | -13.0% |
| EPS (Basic) | ₹-7.39 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Zota Health Care Ltd reported revenue of ₹199 Cr in Q2 FY27, up 54.6% from ₹129 Cr in Q2 FY26 and up 14.8% from ₹174 Cr in Q1 FY27. It posted a net loss of ₹26 Cr for the quarter, against a net loss of ₹16 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹97 Cr (Q4 FY25) to ₹199 Cr (Q2 FY27). The company reported a net loss in 7 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹199 Cr | −₹26 Cr | −13.0% |
| Q1 FY27 | ₹174 Cr | −₹44 Cr | −25.3% |
| Q4 FY26 | ₹163 Cr | −₹14 Cr | −8.9% |
| Q3 FY26 | ₹143 Cr | −₹30 Cr | −20.7% |
| Q2 FY26 | ₹129 Cr | −₹16 Cr | −12.6% |
| Q1 FY26 | ₹104 Cr | −₹14 Cr | −13.3% |
| Q4 FY25 | ₹97 Cr | −₹13 Cr | −13.3% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 49.38% of Zota Health Care Ltd's shares as of Sept 2026, against 55.81% in Sept 2025 (−6.43 percentage points). Delivery averaged 59.1% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.
1. Manufacturing and Marketing of Pharmaceutical Products-This segment manufactures and markets pharmaceutical products. It offers generic drugs, OTC pharmaceutical products, ayurvedic products, and nutraceutical products.
1. Manufacturing and Marketing of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹44,982 Cr | 43.4 | 48.91% | ₹1,184 Cr | +3.3% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹20,245 Cr | 30.5 | 12.36% | ₹2,603 Cr | +11.7% |
| Bliss Gvs Pharma Ltd. | ₹6,817 Cr | 53.9 | 11.60% | ₹313 Cr | +426.3% |
| Zota Health Care Ltd | ₹4,585 Cr | n/m | -16.05% | ₹199 Cr | -15.1% |
| Amrutanjan Health Care Ltd. | ₹1,467 Cr | 25.3 | 16.62% | ₹135 Cr | -28.1% |
| Jenburkt Pharmaceuticals Ltd. | ₹433 Cr | 12.5 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹256 Cr | 15.7 | 25.30% | — | — |
| Vista Pharmaceuticals Ltd. | ₹40 Cr | n/m | -10.82% | — | -37.1% |
| Welcure Drugs & Pharmaceuticals | ₹23 Cr | n/m | -5.50% | — | -64.2% |
Listed by market capitalisation. Ratios are shown for context only.
Zota Health Care Ltd is trading at ₹1,297.00, with a market capitalisation of ₹4,585 Cr.
Zota Health Care Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Zota Health Care Ltd has a return on equity of -16.05%.
Zota Health Care Ltd is listed on the NSE under the symbol ZOTA.
Zota Health Care Ltd's share price is down 15.1% over one year and up 4.5% over three months. Its 52-week range is ₹1,022.00 to ₹1,740.00.
In Q2 FY27, Zota Health Care Ltd reported revenue of ₹199 Cr and net profit of ₹-26 Cr, with basic EPS of ₹-7.39 (consolidated, parsed from the company's exchange filing).
Zota Health Care Ltd reported revenue of ₹199 Cr in Q2 FY27, up 54.6% from ₹129 Cr in Q2 FY26 and up 14.8% from ₹174 Cr in Q1 FY27.
Promoters held 49.38% of Zota Health Care Ltd's shares as of Sept 2026, against 55.81% in Sept 2025 (−6.43 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.